{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1116.205",
  "meta": {
    "versionId": "3",
    "lastUpdated": "2015-09-11T01:00:03.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.205",
  "version": "20150911",
  "name": "Fulvestrant",
  "status": "active",
  "date": "2015-09-11T01:00:03-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "350934",
            "display": "fulvestrant 50 MG/ML"
          },
          {
            "code": "575925",
            "display": "fulvestrant 50 MG/ML [Faslodex]"
          },
          {
            "code": "727761",
            "display": "2.5 ML fulvestrant 50 MG/ML Prefilled Syringe"
          },
          {
            "code": "727762",
            "display": "5 ML fulvestrant 50 MG/ML Prefilled Syringe"
          },
          {
            "code": "727954",
            "display": "5 ML fulvestrant 50 MG/ML Prefilled Syringe [Faslodex]"
          }
        ]
      }
    ]
  }
}